All ingredient lists · Model report

Ingredient list

CJC-1295 without DAC 5 mg + Ipamorelin 5 mg.

Declared composition for LIRAVEXIN catalog number CP10. This page lists what the catalog names. It is not a laboratory assay and not a test result.

Ingredient list — declared composition, not a test result
GS Laboratory

Prepared as a catalog companion to the model testing report.

Ingredient list

Declared composition for a LIRAVEXIN catalog item — not a tested result

Catalog number
CP10
Product name
CJC-1295 without DAC 5 mg + Ipamorelin 5 mg
Labelled amount
10 mg
Pack, as catalogued
10 mg × 10 vials
Physical form
Lyophilised powder in a vial
Catalog
LIRAVEXIN (www.liravexin.com)

Declared ingredients

Ingredient Amount as declared Public identity
CJC-1295 without DAC5 mgAlso known in public literature as modified GRF (1–29) or Mod GRF 1–29: a tetrasubstituted analogue of growth hormone-releasing hormone (1–29).
Public sequence / structure: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg
Ipamorelin5 mgA pentapeptide growth hormone secretagogue (ghrelin-receptor agonist).
Public sequence / structure: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Other constituents—Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here.

Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.

Notes

This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.

The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.

Declared composition — not a test result · CP10